Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 kb
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Table S1. Standardized asthma history obtained by study physicians at both study visits. Table S2. C...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Scatter plot of ACQ and miniAQLQ scores. Table S1. Characteristics of asthma. Table S2. Lung functio...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...
International audienceBACKGROUND: To analyse the efficacy of fluticasone propionate (FP) alone and c...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Table S1. Standardized asthma history obtained by study physicians at both study visits. Table S2. C...
Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...
AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...
Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...
Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB
Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...
Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...
List of Institutions and Independent Ethics Committees/Institutional Review Boards for Studies HZA10...
Scatter plot of ACQ and miniAQLQ scores. Table S1. Characteristics of asthma. Table S2. Lung functio...
Flowchart of the study population. Detailed information on characteristics and co-medication of case...
Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...
International audienceBACKGROUND: To analyse the efficacy of fluticasone propionate (FP) alone and c...
Algorithm used to calculate current and past use in the cohort analysis. Schematic description of th...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Table S1. Standardized asthma history obtained by study physicians at both study visits. Table S2. C...